Thursday, February 28, 2019

December 2018 Medicaid & CHIP Eligibility and Enrollment Report


 
View in browser | Distributed by Center for Medicaid and CHIP Services (CMCS)
Medicaid.gov
Today the Centers for Medicare & Medicaid Services (CMS) released the December 2018 monthly report on state Medicaid and Children's Health Insurance Program (CHIP) eligibility and enrollment data. These data reflect a range of indicators related to key application, eligibility, and enrollment processes within the state Medicaid and CHIP agency.
The full report is available on Medicaid.gov.

Stay connected with Medicaid.gov and CMS:
Get email updates
Twitter
YouTube
RSS
FAQ

Who to Contact: Social Security or Medicare?

" "Sometimes it’s confusing to know who to contact and for what. Social Security and Medicare offer related services, so people aren’t always certain who does what. This “cheat sheet” can help.
Contact Social Security to:
  • See if you’re eligible for Medicare;
  • Create a my Social Security account to do things like request a replacement Medicare card and report a change of address, name, or phone number;
  • Sign up for Medicare Part A (Hospital Insurance) and Medicare Part B (Medical Insurance);
  • Apply for Extra Help with Medicare prescription drug coverage (Part D) costs;
  • Report a death; and
  • Appeal an Income-Related Monthly Adjustment Amount (IRMAA) decision (for people who pay a higher Part B and/or Part D premium if their income is over a certain amount).
Find information on how to do all of this and more on Social Security’s Medicarewebsite.
Contact Medicare to:
  • See what services Medicare covers;
  • Get detailed information about Medicare health and prescription drug plans in your area, including costs and services;
  • Choose and enroll in a Medicare health or prescription drug plan that meets your needs;
  • Find a Medicare Supplement Insurance (Medigap) policy in your area;
  • Find doctors, health care providers, and suppliers who participate in Medicare;
  • Get information and forms for filing a Medicare appeal or for letting someone speak with Medicare on your behalf;
  • Compare the quality of care provided by plans, nursing homes, hospitals, home health agencies, and dialysis facilities; and
  • View Medicare publications.
Visit the Medicare website for more information on these services.
If you need to find out your claim status, find out deductibles, or get answers to premium payment questions, you can call 1-800-MEDICARE (1-800-633-4227; TTY: 1-877-486-2048).
Determining who to contact is the first step in getting the answers you need. Please share these lists with family and friends who need to know more about Social Security and Medicare.
https://blog.ssa.gov/who-to-contact-social-security-or-medicare/?utm_campaign=&utm_content=&utm_medium=email&utm_source=govdelivery

Find Resources to Improve Your Living Conditions

January 31, 2019
According to the U.S. Census Bureau, 12% of Americans, or almost 40 million people, are living in poverty. Benefits.gov offers information on a range of resources that can help improve the living conditions of individuals and their families. If you are facing challenges such as homelessness, poor health, or need financial support, you may be eligible for Federal assistance through the following programs.
Housing
If you need housing support, the U.S. Department of Housing and Urban Development (HUD) offers a Resource Locator Tool, where you can view housing resources offered in your state, from local shelter information to guidance on foreclosure prevention. If you have a low income and need help finding affordable rental housing, you may be eligible for HUD’s Housing Choice Voucher Program (Section 8)offered through your local Public Housing Authority.
Healthcare
Medicaid provides free or low-cost health coverage to eligible low-income adults and children. Medicaid programs and eligibility requirements vary from state to state, but Healthcare.gov allows you to search by state to find requirements. The U.S. Department of Health and Human Services (HHS)offers the Children’s Health Insurance Program (CHIP), providing health coverage to children in families that may not qualify for Medicaid. CHIP benefits and eligibility requirements are different in each state, but InsureKidsNow.gov provides information on the available programs by state.
Financial Assistance
HHS offers many programs with the goal of improving the well-being of individuals and families, including Temporary Assistance for Needy Families (TANF). TANF provides financial assistance to states to help families with things like childcare, employment services, housing, and other necessary expenses. The U.S. Department of Agriculture Supplemental Nutrition Assistance Program (SNAP)offers benefits to eligible low-income people and families. Use the SNAP Pre-Screening Tool to help determine if you are eligible to receive SNAP benefits.
To find additional housing, healthcare, or financial resources, visit our Browse by Category page. We also encourage you to take our Benefit Finder questionnaire to find out what additional assistance you may be eligible to receive.
https://www.benefits.gov/compass/article/364?utm_source=govdelivery&utm_medium=email&utm_campaign=dr344

Health care spending is more than just the parts you see

People focus on the health costs that are most tangible and sometimes outrageous to them: their deductibles, and drug costs, and surprise medical bills, and the annual increase in the share of the premium they pay. But there's more that gets less attention because it's not as visible to them.
Why it matters: To really understand how Medicare for All or any other big change in health care financing would affect them, people need to understand how they would impact their overall family health budgets. Few people think about the other health costs they pay: their taxes to support health care, or what their employers are paying towards premiums (which is depressing their wages).
Between the lines: Consider this hypothetical example of a total family health “budget”:
  • The Browns, a family of four with at least one member in poor health and a $50,000 income, have standard employer coverage much like 156 million other Americans. They spend $9,250 per year (19% of their income) on health.
  • This includes $3,950 (8% of their income) in out-of-pocket health spending, $3,900 (8% of their income) in health insurance premiums, and, although they are almost certainly not aware of it, approximately $1,400 (3% of their income) in state and federal taxes that fund health programs.
  • The Browns are not taxed on the contributions their employer makes toward health insurance premiums, which economists generally say offset wages. Their employer is contributing an additional $13,050 to their health insurance premiums, as well as $750 in Medicare payroll taxes.
  • When combined, the Brown’s spending on health care and the money spent by their employer on their behalf totals a considerable $23,050. And remember, they make $50,000.
A few ideas that could help people learn more about their health total care spending and how reform proposals might affect their health spending:  
  • The IRS and states could include a simple pie chart on everyone’s tax forms, showing taxpayers where their tax dollars go today.
  • Along with estimating the impact of health reform legislation on the federal budget, or the number of uninsured, the CBO could estimate its impact on typical family budgets, taking into account all of the forms of health spending families have today. Organizations like ours could do this as well.
What to watch: This could be particularly important when analyzing Medicare for All proposals, since they would so significantly alter the financing of health care by shifting it from premiums and out-of-pocket costs to taxes.
  • A Medicare for All plan would likely reduce what the nation spends on health care by lowering payment rates to providers and creating administrative efficiencies. The average family would likely pay less, but how much is hard to say without more details.
  • However, by changing the financing so significantly, there would likely be both winners and losers. Low-income people and sick people might pay less, and higher-income people and those who are healthy could pay more.
The bottom line: We can only get a clear picture of how family finances would be affected by Medicare for All, or any other significant overhaul of the health care system, by looking at the totality of what they pay now.
https://www.axios.com/understanding-health-care-spending-46e21c47-79ee-474b-80ff-778a705cdcae.html?utm_campaign=KFF%3A%20Drew%27s%20Columns&utm_medium=email&_hsenc=p2ANqtz-8LC489zrRwouoPFZbp5bDc1uOFXrYJKZQMe6-MYzKaEy9QNKlre8MFeqqGgV2cBYqULGF6lV_fgdFduHoa2Tn5iQyS3w&_hsmi=70342486&utm_content=70342486&utm_source=hs_email&hsCtaTracking=66083bbc-90fb-439a-a527-852ede240988%7Ca5ccaddb-8634-4d8a-95c0-17d0775a9d86

CMS updates hospital star ratings but seeks feedback on more changes


MARIA CASTELLUCCI  February 28, 2019 10:10 AM
The CMS is seeking comments from stakeholders on suggested changes to the hospital star ratings even as the agency updates the Hospital Compare website with the newest ratings after a nearly 15-month hiatus.
In a press release Thursday morning, the CMS said a public comment page has opened for stakeholders to provide feedback on the possibility that the agency will separate hospitals into "peer groups" when comparing how they perform on the 57 measures used to assign star ratings. The agency said hospitals could be separated by bed-size and status like community or teaching. A CMS agency official said the new comment period is in response to feedback from stakeholders that the star ratings methodology needs to be changed in order to better assess quality of care at hospitals.
"We are putting out (this comment period) to get a greater breath of input on any potential future changes that we might continue to make to the program," she added. But even as the CMS acknowledges opportunities to improve the ratings system, the CMS official said she stands by the current star ratings as a helpful tool for consumers.
The CMS has been in hot water over its hospital star ratings since they first published on Hospital Compare in July 2016. Hospital groups argue that the ratings inaccurately depict quality of care at hospitals. The pushback hit a peak last year after a preview of the July 2018 update had some hospitals seeing drastic changes to their star ratings in just six months. The controversy led the CMS to withhold a new release of the star ratings since December 2017.
The suggestion to separate hospitals into peer groups addresses a common sticking point for teaching hospitals who say they get low ratings because their performance on measures is compared to specialty and small community hospitals that don't have the same case mix, including patients with socioeconomic challenges.
A Modern Healthcare analysis last year found that specialty hospitals receive disproportionately higher ratings than teaching hospitals.
The public comment period will end March 29.
The latest star ratings update to Hospital Compare didn't see any changes from the preview report the CMS released to providers in December, an agency official said. At the time, hospital stakeholders expressed disappointment that the February star ratings won't have substantial changes to the methodology.
The one change the CMS made to the February star ratings was how the healthcare-associated infections measures used in the methodology were weighted, which allowed those measures to have a greater impact on a hospital's overall rating. The CMS also will remove measures that have statistically significant negative loading from the star ratings, but that didn't happen in the February star ratings release, the CMS official said.

Senate Drug Hearing Produces Few Fireworks

Merck's CEO said sick patients are subsidizing healthy patients' insurance premiums.
By Timothy Annett and Anna Edney | February 26, 2019 at 06:54 PM
A highly anticipated Senate hearing on surging drug prices that was billed as a replay of a decades-ago public reckoning for the tobacco industry produced few memorable fireworks.
Instead, what emerged was a broad recognition that the U.S. health care system is complex, and that easy fixes are in short supply.
Lawmakers from the Senate Finance Committee largely refrained from bashing seven senior pharmaceutical executives who came to Capitol Hill to explain why medicines cost so much. Many of the techniques the industry has used to preserve its profits from blockbuster drugs came in for criticism, but company officials were able to place much of the blame on a patchwork of incentives that culminates in high out-of-pocket costs for patients.
“I feel like I need a Ph.D. in prescription drug-pricing to understand how the heck this industry works,” said Senator Maggie Hassan, the New Hampshire Democrat.
The hearing marks the start of what is likely to be a prolonged bipartisan push to tackle soaring health costs that could extend far beyond drugmakers. Republicans and Democrats have been largely in agreement on the need to address an acute source of strain for many American families. The Trump administration has proposed new rules and approved a slew of new generic drugs, and has signaled openness to more ambitious changes.
Iowa Republican Chuck Grassley, the committee’s chairman, said it wasn’t yet clear which issues the Senate would act on first. Grassley has previously pushed legislation that would do away with various moves branded drugmakers have used to thwart generic competition.
“They realize there’s a problem and I think every one of them is going to help us solve it,” Grassley said to reporters after the hearing concluded.
Investors appeared relieved that the industry was spared a pointed public thrashing. The S&P 500 Pharmaceuticals Index, which includes heavyweights such as Bristol-Myers Squibb Co. and Pfizer Inc., was modestly higher in midafternoon trading, bucking a slide in the broader U.S. stock market.
“The only way things could have gone sideways is if a CEO got baited into losing their cool and going off script,” said Rob Smith, an analyst at Capital Alpha Partners, a Washington-based research firm. “They’ve stuck to the same talking points we’ve heard for years.”
Familiar Argument
The most intractable issue in crafting any new legislation is likely to be determining which part of the drug-supply chain is most responsible for increasing prices and which part of the industry can withstand major changes without destroying jobs or profits.
At Tuesday’s hearing, pharmaceutical executives stuck to their oft-rehearsed argument that rebates for drug-plan middlemen have clouded the true price of prescription drugs. Most of them said that they would lower list prices for their drugs if rebates were to disappear — a proposal that would upend the pharmacy-benefit management business.
Last year, the three largest PBMs — CVS Health Corp., UnitedHealth Group Inc.’s OptumRx and Cigna Corp.’s Express Scripts unit — processed 76% of U.S. prescriptions, according to preliminary estimates by the Drug Channels Institute.
Lawmakers had warned drugmakers not to blame others for higher costs. Oregon Senator Ron Wyden, the ranking Democrat on the panel, called the idea that rebates and other fees are to blame for high drug costs “window dressing,” suggesting pharmaceutical companies bare the bulk of responsibility for high patients costs for lifesaving medicines.
But Wyden also indicated PBMs and health insurers would have their turn before the panel. Indeed, shares of prominent pharmacy-benefit managers declined more deeply than most drug stocks on Tuesday. Cigna saw its shares slide by as much as 1.8% as of 2:20 p.m. in New York, while CVS fell by as much as 1 percent.
Economic Handcuffs
Merck & Co. Chief Executive Officer Kenneth Frazier said that rebates force drug companies to set a high price for their medicines. In prepared remarks to the committee, he said the current system is designed to keep insurance premiums low, which means “sick patients are essentially subsidizing healthy patients.”
Frazier said those economics handcuff drugmakers. “If you bring a product to the market with a low list price in this system you get punished financially,” he said during the hearing.
Lawmakers also probed the executives on patent protections that shield many blockbuster therapies from competition — in some cases, for years past when the original patent for the medications lapsed. Senators pushed AbbVie Inc. CEO Richard Gonzalez on the fortress of 136 patents the company has erected around arthritis drug Humira, one of the biggest-selling medicines in the world.
“That patent portfolio evolved as we discovered and learned new things about Humira,” Gonzalez said. The main patent, known as the composition-of-matter patent, expired in 2016, but AbbVie was able to continue to protect the drug with patents for new uses.
Senator John Cornyn, a Texas Republican, said he would suggest the Judiciary Committee on which he also sits look into patents.
—With assistance from Riley Griffin and Bailey Lipschultz.
Copyright 2019 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
https://www.thinkadvisor.com/2019/02/26/senate-drug-hearing-produces-few-fireworks/?slreturn=20190128101916

What a Complete Blood Count Says About Your Health


December 12, 2017 / Family Medicine
The CBC can explain fatigue, bruising, swelling and more
Your complete blood count (CBC) is a quick, easy and practically painless blood test. “It gives your doctor an overview of your health,” explains family medicine physician Daniel Allan, MD. Tap or click to learn more:
One of the most common blood tests
The CBC is typically part of your regular checkup. "I also order a complete blood count for patients who are weak or tired; have swelling, bruising or bleeding; or who may have an infection,” Dr. Allan. explains. "This test also can help me check how a patient’s body is responding to medication.”
What if your test results are abnormal? Don't worry. They don't necessarily mean you’re sick.
Diet, menstrual cycle, medication and other factors can affect your scores. Talk to your doctor about your CBC results. He or she will explain any areas of concern and help you determine next steps.